Issue 11, 2024

Lipid sulfoxide polymers as potential inhalable drug delivery platforms with differential albumin binding affinity

Abstract

Inhalable nanomedicines are increasingly being developed to optimise the pharmaceutical treatment of respiratory diseases. Large lipid-based nanosystems at the forefront of the inhalable nanomedicines development pipeline, though, have a number of limitations. The objective of this study was, therefore, to investigate the utility of novel small lipidated sulfoxide polymers based on poly(2-(methylsulfinyl)ethyl acrylate) (PMSEA) as inhalable drug delivery platforms with tuneable membrane permeability imparted by differential albumin binding kinetics. Linear PMSEA (5 kDa) was used as a hydrophilic polymer backbone with excellent anti-fouling and stealth properties compared to poly(ethylene glycol). Terminal lipids comprising single (1C2, 1C12) or double (2C12) chain diglycerides were installed to provide differing affinities for albumin and, by extension, albumin trafficking pathways in the lungs. Albumin binding kinetics, cytotoxicity, lung mucus penetration and cellular uptake and permeability through key cellular barriers in the lungs were examined in vitro. The polymers showed good mucus penetration and no cytotoxicity over 24 h at up to 1 mg ml−1. While 1C2-showed no interaction with albumin, 1C12-PMSEA and 2C12-PMSEA bound albumin with KD values of approximately 76 and 10 μM, respectively. Despite binding to albumin, 2C12-PMSEA showed reduced cell uptake and membrane permeability compared to the smaller polymers and the presence of albumin had little effect on cell uptake and membrane permeability. While PMSEA strongly shielded these lipids from albumin, the data suggest that there is scope to tune the lipid component of these systems to control membrane permeability and cellular interactions in the lungs to tailor drug disposition in the lungs.

Graphical abstract: Lipid sulfoxide polymers as potential inhalable drug delivery platforms with differential albumin binding affinity

Supplementary files

Article information

Article type
Paper
Submitted
12 Dec 2023
Accepted
16 Apr 2024
First published
22 Apr 2024

Biomater. Sci., 2024,12, 2978-2992

Lipid sulfoxide polymers as potential inhalable drug delivery platforms with differential albumin binding affinity

G. R. Ediriweera, N. J. Butcher, A. Kothapalli, J. Zhao, J. T. Blanchfield, C. N. Subasic, J. L. Grace, C. Fu, X. Tan, J. F. Quinn, D. B. Ascher, M. R. Whittaker, A. K. Whittaker and L. M. Kaminskas, Biomater. Sci., 2024, 12, 2978 DOI: 10.1039/D3BM02020G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements